NO881482L - Fremgangsmaate for fremstilling av di-t-butylfenoler. - Google Patents

Fremgangsmaate for fremstilling av di-t-butylfenoler.

Info

Publication number
NO881482L
NO881482L NO88881482A NO881482A NO881482L NO 881482 L NO881482 L NO 881482L NO 88881482 A NO88881482 A NO 88881482A NO 881482 A NO881482 A NO 881482A NO 881482 L NO881482 L NO 881482L
Authority
NO
Norway
Prior art keywords
phenoles
butyl
procedure
preparation
butyl phenoles
Prior art date
Application number
NO88881482A
Other languages
English (en)
Other versions
NO881482D0 (no
NO178619B (no
NO178619C (no
Inventor
Robert Allan Scherrer
Mark Allan Rustad
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of NO881482D0 publication Critical patent/NO881482D0/no
Publication of NO881482L publication Critical patent/NO881482L/no
Publication of NO178619B publication Critical patent/NO178619B/no
Publication of NO178619C publication Critical patent/NO178619C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO881482A 1987-04-06 1988-04-06 Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler NO178619C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3453787A 1987-04-06 1987-04-06

Publications (4)

Publication Number Publication Date
NO881482D0 NO881482D0 (no) 1988-04-06
NO881482L true NO881482L (no) 1988-10-07
NO178619B NO178619B (no) 1996-01-22
NO178619C NO178619C (no) 1996-05-02

Family

ID=21877034

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881482A NO178619C (no) 1987-04-06 1988-04-06 Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler

Country Status (12)

Country Link
EP (1) EP0286364B1 (no)
JP (1) JP2514999B2 (no)
KR (1) KR960009115B1 (no)
AU (1) AU615182B2 (no)
CA (1) CA1322374C (no)
DE (1) DE3850598T2 (no)
DK (1) DK177088A (no)
ES (1) ES2056105T3 (no)
IL (1) IL85896A (no)
NO (1) NO178619C (no)
NZ (1) NZ224079A (no)
ZA (1) ZA882251B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264578A (en) * 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
NZ226621A (en) * 1987-11-13 1991-12-23 Riker Laboratories Inc Di-tert butyl phenols substituted by alkoxy, benzyloxy, or benzylthio groups; pharmaceutical compositions containing them
US5047555A (en) * 1988-12-13 1991-09-10 Tanabe Seiyaku Co., Ltd. 4-aminophenol derivatives and processes for preparing the same
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
IT1256870B (it) * 1992-02-13 1995-12-27 Rotta Research Lab Derivati bis-tetrazolici ad attivita' antiallergica e citoprotettiva
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5534641A (en) 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5675033A (en) 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5741896A (en) 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5760276A (en) * 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
WO2000061182A2 (en) * 1999-04-14 2000-10-19 Allergan Sales, Inc. Methods and compositions for the treatment and prevention of lung disease involving a selective rar-alpha agonist
US6387951B1 (en) 2000-08-29 2002-05-14 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
US6369261B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
PA8578101A1 (es) * 2002-08-13 2004-05-07 Warner Lambert Co Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
AU2013207510A1 (en) 2012-01-06 2014-07-31 The Regents Of The University Of California Compositions, methods of use, and methods of treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1453972A (fr) * 1965-08-12 1966-07-22 Rhone Poulenc Sa Procédé de stabilisation des polyoléfines et nouveaux agents de stabilisation
FR2035771A1 (en) * 1969-03-14 1970-12-24 Aries Robert Salicylaminophenols having analgesic antipy - etic and antiinflammatory activity
GB1307292A (en) * 1969-04-30 1973-02-14 Ciba Geigy Ag Substituted phenols and their use as antioxidants for organic materials
US4128664A (en) * 1977-05-16 1978-12-05 Riker Laboratories, Inc. Substituted benzamides as anti-inflammatory agents
JPS6056130B2 (ja) * 1978-03-20 1985-12-09 久光製薬株式会社 新規なサリチル酸誘導体
DE3521558A1 (de) * 1985-06-15 1986-12-18 Basf Ag, 6700 Ludwigshafen 3-t-butyl-4-hydroxiphenylpropionsaeureaminoalkylamidderivate und damit stabilisiertes organisches material
ZA865090B (en) * 1985-07-22 1988-02-24 Riker Laboratories Inc Substituted di-t-butylphenols
ZA865091B (en) * 1985-07-22 1988-02-24 Riker Laboratories Inc Substituted di-t-butylphenols
US4714776A (en) * 1985-07-22 1987-12-22 Riker Laboratories, Inc. Antiallergic agents
US4667069A (en) * 1985-08-16 1987-05-19 Ranco Incorporated Multiple disc pressure responsive control device

Also Published As

Publication number Publication date
JPH01261379A (ja) 1989-10-18
AU1407388A (en) 1988-10-06
NZ224079A (en) 1990-11-27
KR960009115B1 (en) 1996-07-13
DK177088A (da) 1989-01-12
NO881482D0 (no) 1988-04-06
KR880012534A (ko) 1988-11-28
IL85896A0 (en) 1988-09-30
NO178619B (no) 1996-01-22
DE3850598D1 (de) 1994-08-18
AU615182B2 (en) 1991-09-26
EP0286364A3 (en) 1990-08-01
EP0286364B1 (en) 1994-07-13
EP0286364A2 (en) 1988-10-12
DK177088D0 (da) 1988-03-30
JP2514999B2 (ja) 1996-07-10
ZA882251B (en) 1989-11-29
CA1322374C (en) 1993-09-21
ES2056105T3 (es) 1994-10-01
IL85896A (en) 1993-01-14
NO178619C (no) 1996-05-02
DE3850598T2 (de) 1995-01-05

Similar Documents

Publication Publication Date Title
NO881482L (no) Fremgangsmaate for fremstilling av di-t-butylfenoler.
NO882200D0 (no) Fremgangsmaate for fremstilling av kalsiumsulfat-alfa-halvhydrat.
NO880262L (no) Fremgangsmaate for fremstilling av b avermectiner.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO883813D0 (no) Fremgangsmaate for fremstilling av homopolyamider.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO890159D0 (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO885002D0 (no) FremgangsmŸte for fremstilling av sialocylglycerolipider.
NO882730D0 (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
NO884900L (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO882655L (no) Fremgangsmaate for fremstilling av (e)-2-(p-fluorfenethyl)-3-fluorallylamin.
NO880834L (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO880106D0 (no) Fremgangsmaate til fremstilling av kalknitrogen.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO891020L (no) Fremgangsmaate for fremstilling av buten-1.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO880127L (no) Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
NO880844L (no) Fremgangsmaate for fremstilling av cytotoksiner.
NO169281C (no) Fremgangsmaate for fremstilling av heksanitrostilben.
NO913089D0 (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.
NO871521D0 (no) Fremgangsmaate for fremstilling av benzoksa- henholdsvis benzotia-diazolderivater.